Drug metabolism treated with 3-(Phosphonooxy)propyl (S)-(6-chloro-4-(1-cyclopropylethyl)-3-oxo-3,4-dihydropyrazin-2-yl)(2,6-dichloro-4-(difluoromethox...

Basic Information

ID: ALA3999776

Type: ADME

Description: Drug metabolism treated with 3-(Phosphonooxy)propyl (S)-(6-chloro-4-(1-cyclopropylethyl)-3-oxo-3,4-dihydropyrazin-2-yl)(2,6-dichloro-4-(difluoromethoxy)phenyl)carbamate, disodium salt assessed as alkaline phosphatase (unknown origin)-mediated compound conversion after 120 mins by LC-MS analysis

Format: BAO_0000357

Organism: Homo sapiens

Target:  Alkaline phosphatase, tissue-nonspecific isozyme(ALA5979)

Document:  ALA3997831

Drug metabolism treated with 3-(Phosphonooxy)propyl (S)-(6-chloro-4-(1-cyclopropylethyl)-3-oxo-3,4-dihydropyrazin-2-yl)(2,6-dichloro-4-(difluoromethoxy)phenyl)carbamate, disodium salt assessed as alkaline phosphatase (unknown origin)-mediated compound conversion after 120 mins by LC-MS analysis: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
526.755.435.43